The following is a schedule of financial highlights for the nine months ended September 30, 2025 and 2024:


	Nine months ended September 30, 2025			Nine months ended September 30, 2024
Per Share Data: (a)
Net asset value, beginning of year	$	18.20		$	18.09
Net investment income		1.20			1.33
Net realized and unrealized gain (loss)		0.04			0.01
Net increase in net assets resulting from operations		1.24			1.34
Distributions to stockholders:
From distributable earnings		(1.20	)		(1.23	)
From return of capital		(0.03	)		—
Net asset value, end of period	$	18.21		$	18.20
Per share market value, end of period	$	15.29		$	15.05
Total Return (b)(c)		1.94	%		8.28	%
Net assets, end of period	$	993,287		$	992,685
Shares outstanding, end of period		54,554,634			54,554,634
Ratios to average net assets (c):
Net investment income		6.59	%		7.32	%
Operating expenses	4.78%*			4.95%*
Interest and other credit facility expenses		5.17	%		5.58	%
Total expenses	9.95%*			10.53%*
Average debt outstanding	$	1,084,933		$	1,138,482
Portfolio turnover ratio		34.9	%		16.5	%

(a)

Calculated using the average shares outstanding method.

(b)

Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2024 and December 31, 2023 was $16.16 and $15.03, respectively. Total return does not include a sales load.

(c)

Not annualized for periods less than one year.

* The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the nine months ended September 30, 2025 and 2024, the ratios of operating expenses to average net assets would be 4.79% and 4.96%, respectively, without the performance-based incentive fee waiver. For the nine months ended September 30, 2025 and 2024, the ratios of total expenses to average net assets would be 9.96% and 10.54%, respectively, without the performance-based incentive fee waiver.